Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Oldřich Vyšata:

Lymphocytes in the treatment with interferon beta-1 b. Pavelek Z et al. Mult Scler Relat Disord. (2017)

Breathing Analysis Using Thermal and Depth Imaging Camera Video Records. Procházka A et al. Sensors (Basel). (2017)

ASPIRIN RESISTANCE IN NEUROVASCULAR DISEASES. Vališ M et al. Acta Medica (Hradec Kralove). (2014)

Search results

Items: 1 to 20 of 31

1.

The Concentration of Memantine in the Cerebrospinal Fluid of Alzheimer's Disease Patients and Its Consequence to Oxidative Stress Biomarkers.

Valis M, Herman D, Vanova N, Masopust J, Vysata O, Hort J, Pavelek Z, Klimova B, Kuca K, Misik J, Zdarova Karasova J.

Front Pharmacol. 2019 Aug 28;10:943. doi: 10.3389/fphar.2019.00943. eCollection 2019.

2.

CD4+/CD45RO+: A Potential Biomarker of the Clinical Response to Glatiramer Acetate.

Vališ M, Sobíšek L, Vyšata O, Klímová B, Andrýs C, Vokurková D, Masopust J, Pavelek Z.

Cells. 2019 May 15;8(5). pii: E456. doi: 10.3390/cells8050456.

3.

Monitoring of Lymphocyte Populations During Treatment with Interferon-β-1b to Predict Multiple Sclerosis Disability Progression.

Vališ M, Vyšata O, Sobíšek L, Klímová B, Andrýs C, Vokurková D, Pavelek Z.

J Interferon Cytokine Res. 2019 Mar;39(3):164-173. doi: 10.1089/jir.2018.0100. Epub 2018 Dec 28.

PMID:
30592627
4.

The Complex Behaviour of a Simple Neural Oscillator Model in the Human Cortex.

Cejnar P, Vysata O, Valis M, Prochazka A.

IEEE Trans Neural Syst Rehabil Eng. 2019 Mar;27(3):337-347. doi: 10.1109/TNSRE.2018.2883618. Epub 2018 Nov 28.

PMID:
30507514
5.

Lymphocyte populations and their change during five-year glatiramer acetate treatment.

Pavelek Z, Vyšata O, Sobíšek L, Klímová B, Andrýs C, Vokurková D, Mazurová R, Štourač P, Vališ M.

Neurol Neurochir Pol. 2018 Sep - Oct;52(5):587-592. doi: 10.1016/j.pjnns.2018.08.001. Epub 2018 Aug 18.

PMID:
30190211
6.

Machine Learning in Rehabilitation Assessment for Thermal and Heart Rate Data Processing.

Prochazka A, Charvatova H, Vaseghi S, Vysata O.

IEEE Trans Neural Syst Rehabil Eng. 2018 Jun;26(6):1209-1214. doi: 10.1109/TNSRE.2018.2831444.

PMID:
29877845
7.

Fibrin Clot Architecture in Acute Ischemic Stroke Treated With Mechanical Thrombectomy With Stent-Retrievers - Cohort Study.

Krajíčková D, Krajina A, Šteiner I, Vyšata O, Herzig R, Lojík M, Chovanec V, Raupach J, Renc O, Waishaupt J, Vítková E, Dulíček P, Čabelková P, Vališ M.

Circ J. 2018 Feb 23;82(3):866-873. doi: 10.1253/circj.CJ-17-0375. Epub 2017 Nov 23.

8.

Lymphocytes in the treatment with interferon beta-1 b.

Pavelek Z, Vyšata O, Klímová B, Andrýs C, Vokurková D, Vališ M.

Mult Scler Relat Disord. 2017 Nov;18:29-32. doi: 10.1016/j.msard.2017.08.020. Epub 2017 Sep 6.

PMID:
29141817
9.

Mechanical recanalization in ischemic anterior circulation stroke within an 8-hour time window: a real-world experience.

Krajíčková D, Krajina A, Herzig R, Lojík M, Chovanec V, Raupach J, Vítková E, Waishaupt J, Vyšata O, Vališ M.

Diagn Interv Radiol. 2017 Nov-Dec;23(6):465-471. doi: 10.5152/dir.2017.17049.

10.

Breathing Analysis Using Thermal and Depth Imaging Camera Video Records.

Procházka A, Charvátová H, Vyšata O, Kopal J, Chambers J.

Sensors (Basel). 2017 Jun 16;17(6). pii: E1408. doi: 10.3390/s17061408.

11.

Concentration of Donepezil in the Cerebrospinal Fluid of AD Patients: Evaluation of Dosage Sufficiency in Standard Treatment Strategy.

Valis M, Masopust J, Vysata O, Hort J, Dolezal R, Tomek J, Misik J, Kuca K, Karasova JZ.

Neurotox Res. 2017 Jan;31(1):162-168. doi: 10.1007/s12640-016-9672-y. Epub 2016 Oct 7.

12.

Microsoft Kinect Visual and Depth Sensors for Breathing and Heart Rate Analysis.

Procházka A, Schätz M, Vyšata O, Vališ M.

Sensors (Basel). 2016 Jun 28;16(7). pii: E996. doi: 10.3390/s16070996.

13.

Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome.

Pavelek Z, Vyšata O, Tambor V, Pimková K, Vu DL, Kuča K, Šťourač P, Vališ M.

Biomed Rep. 2016 Jul;5(1):35-40. Epub 2016 Apr 28.

14.

Motion tracking and gait feature estimation for recognising Parkinson's disease using MS Kinect.

Ťupa O, Procházka A, Vyšata O, Schätz M, Mareš J, Vališ M, Mařík V.

Biomed Eng Online. 2015 Oct 24;14:97. doi: 10.1186/s12938-015-0092-7.

15.

Trends in the treatment of risk factors for stroke in a Czech stroke unit.

Simunek L, Krajickova D, Vysata O, Valis M.

Open Med (Wars). 2015 Oct 26;10(1):364-369. doi: 10.1515/med-2015-0060. eCollection 2015.

16.

Separation of overlapping dental arch objects using digital records of illuminated plaster casts.

Yadollahi M, Procházka A, Kašparová M, Vyšata O, Mařík V.

Biomed Eng Online. 2015 Jul 11;14:67. doi: 10.1186/s12938-015-0066-9.

17.

The dependence of age on ulnar nerve conductive study parameter adaptation after compressive ulnar neuropathy operations in the elbow.

Radka N, Oldřich V, Edvard E, Martin K, Martin S, Aleš P, Kunc P, Martin V.

Acta Neurochir (Wien). 2015 Sep;157(8):1405-9; discussion 1409. doi: 10.1007/s00701-015-2489-2. Epub 2015 Jul 2.

PMID:
26126764
18.

ASPIRIN RESISTANCE IN NEUROVASCULAR DISEASES.

Vališ M, Krajíčková D, Malý J, Malý R, Fátorová I, Vyšata O, Herzig R.

Acta Medica (Hradec Kralove). 2014;57(4):157-61. doi: 10.14712/18059694.2015.81.

19.

Painful lumbosacral plexopathy: a case report.

Ehler E, Vyšata O, Včelák R, Pazdera L.

Medicine (Baltimore). 2015 May;94(17):e766. doi: 10.1097/MD.0000000000000766.

20.

Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia.

Masopust J, Andrýs C, Bažant J, Vyšata O, Kuca K, Vališ M.

Neuropsychiatr Dis Treat. 2015 Mar 6;11:619-23. doi: 10.2147/NDT.S80746. eCollection 2015.

Supplemental Content

Loading ...
Support Center